Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Mrozek K, Dohner H, Bloomfield CD . Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances. Curr Opin Hematol 2007; 14: 106–114.

    Article  CAS  PubMed  Google Scholar 

  2. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

    Article  PubMed  Google Scholar 

  3. Miller CA, Wilson RK, Ley TJ . Genomic landscapes and clonality of de novo AML. N Engl J Med 2013; 369: 1473.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079–1089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17: 13–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118: 5573–5582.

    Article  CAS  PubMed  Google Scholar 

  7. Hock H . A complex Polycomb issue: the two faces of EZH2 in cancer. Genes Dev 2012; 26: 751–755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Shih AH, Abdel-Wahab O, Patel JP, Levine RL . The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012; 12: 599–612.

    Article  CAS  PubMed  Google Scholar 

  9. Li B, Carey M, Workman JL . The role of chromatin during transcription. Cell 2007; 128: 707–719.

    Article  CAS  PubMed  Google Scholar 

  10. Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005; 106: 3747–3754.

    Article  CAS  PubMed  Google Scholar 

  11. Vassiliou GS, Cooper JL, Rad R, Li J, Rice S, Uren A et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat Genet 2011; 43: 470–475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Valk PJ, Delwel R, Lowenberg B . Gene expression profiling in acute myeloid leukemia. Curr Opin Hematol 2005; 12: 76–81.

    Article  CAS  PubMed  Google Scholar 

  13. Marzluff WF, Wagner EJ, Duronio RJ . Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet 2008; 9: 843–854.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879–3884.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 2013; 45: 242–252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K . Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20: 1123–1136.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Anne-Marie Imbert for the help with primary cells; all the Duprez Lab personnel for helpful discussions and the onco-genomic facility at IPC for microarray analysis. This work was supported by the Fondation de France grants 2008002092 and 201200029166, by the Laurette Fugain grants ALF 08/04 and 09/08, by the Fondation pour la Recherche Médicale (FRM) grant INE201000518534 and by the SIRIC leukemia program (INCa-DGOS-Inserm 6038). GT was supported by the FRM and Cancéropole PACA. AP was supported by Marie Curie research training fellowship (MRTN-CT-2006-035733) and the FRM. Samples of human origin and associated data were obtained from the IPC/CRCM Tumor Bank (Biological Resource Centre in Oncology), that operates under authorization #AC-2007-33 granted by the French Ministry of Research (Ministère de la Recherche et de l’Enseignement Supérieur). This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (grant RP-PG-0108-10093, supporting DG and AI). This work was enabled by the NIHR Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London.

Disclaimer

The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to B Calmels or E Duprez.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tiberi, G., Pekowska, A., Oudin, C. et al. PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia. Leukemia 29, 1202–1206 (2015). https://doi.org/10.1038/leu.2014.339

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2014.339

This article is cited by

Search

Quick links